Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma Interventions: Drug: Lenvatinib Sponsors: Asan Medical Center; Eisai Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials